4
Changes in Ownership
AbbVie Inc. Filed Acc 0002004979-26-000002
EVP, R&D and CSO acquired 18,137 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thakkar Roopal EVP, R&D and CSO | 2026-02-18 | Grant or award | +6,015 | 48,291 | D: show line 1 in the form | ||
| Thakkar Roopal EVP, R&D and CSO | 2026-02-18 | Grant or award | +2,138 | 50,429 | D: show line 2 in the form | ||
| Thakkar Roopal EVP, R&D and CSO | 2026-02-18 | Grant or award | +3,346 | 53,775 | D: show line 3 in the form | ||
| Thakkar Roopal EVP, R&D and CSO | 2026-02-18 | Grant or award | +6,638 | 60,413 | D: show line 4 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Thakkar Roopal EVP, R&D and CSO | 2026-02-18 | Grant or award · Option (Right to buy) | +21,937 | 21,937 | D: show line 5 in the form |
Loading xslF345X05/form4-02202026_110244.xml…